ALEMBIC PHARMA LTD

Alembic Pharmaceuticals: Plans Meeting With Analysts And Investors On September 23 At 10 AM

Alembic Pharma Plans Investor Meet in Mumbai on Sept 23, 2026

Alembic Pharmaceuticals to hold one-on-one investor/analyst meetings on 23rd Sept, 2026 in Mumbai. Discussions will follow publicly available info; no unpublished price-sensitive data will be shared. Source: BSE

Alembic Pharma: Company Usfda Issues Eir, Closes Inspection At Vadodara Bioequivalence Facility

Alembic Pharma's Vadodara Plant Clears USFDA Inspection with No Observations

Alembic Pharma's Vadodara facility cleared USFDA inspection held Aug 31-Sep 10, 2026. No Form 483 observations were noted, confirming compliance with USFDA standards. Source: ScoutQuest

Alembic Pharmaceuticals: Completes Unannounced USFDA Inspection at Bioequivalence Facility Without Any Form 483 Remarks.

Alembic Pharma Sets Up Dubai Unit to Boost Global Reach

Alembic Pharmaceuticals has incorporated a wholly owned subsidiary, Alembic Pharmaceuticals Global FZCO, in Dubai. The subsidiary aims to explore business opportunities, promote, sell, and distribute pharmaceutical products. Source: BSE

Alembic Pharmaceuticals: Plans Investor And Analyst Meetings On September 1 And 2.

Alembic Pharma to Host Investor Meets on Sep 1-2, 2026

Alembic Pharmaceuticals schedules investor/analyst meetings on Sep 1-2, 2026. Meetings include Dolat Capital, ICICI Securities, HSBC, and others; no UPSI will be shared. Source: BSE